In the Nemechek Protocol, one of the most common concerns parents raise is: “We’ve been doing the oils and inulin, but my child doesn’t seem to be getting better.” In this clinical review, Dr. Patrick Nemechek explains how he thinks through a lack of progress over months—especially when families focus on the wrong variables.
In his framework, the first question is not whether the olive oil or fish oil are “off.” Instead, he looks first at whether the child’s gut bacteria are balanced, because that balance is what he expects to drive the first noticeable improvements. He notes that short-term issues (such as sinus infections) can slow progress briefly, but the situations that worry parents most are those where, after several months, progress appears to stop.
This article proposal summarizes his discussion of inulin—why it often works well, why a small group of children cannot tolerate even tiny amounts, and what he calls “inulin failure,” when inulin stops working after months or years.
Dr. Nemechek’s priority when improvement is slow: gut bacteria balance
Dr. Nemechek describes gut balance as the “number one thing” he tries to determine when a child is not improving as expected. In his view, the most important goal early on is not perfect recovery all at once, but starting to see improvement—what some parents describe as a clear “awakening” in younger children, or a subtler “awareness” in older individuals.
When inulin is successful, he says many families see a rapid increase in responsiveness—paying attention more, hearing you more, and responding more quickly—followed by broad gains over time. If specific areas lag behind even after that initial improvement, he mentions vagal stimulation as something he discusses for later support, but in this video his focus remains on whether the gut-balancing step (inulin) is working.
Why inulin (“bird food”) often helps—and where it tends to stop working
Dr. Nemechek refers to inulin as “bird food” and says it tends to work especially well in younger kids. He also describes a general age-related trend:
- Inulin often works very well in younger children.
- In the 10–20 year age bracket, it starts to be less reliable—though he emphasizes there are exceptions (he cites seeing an 11- and 14-year-old doing great on inulin).
- In his general experience, inulin is “generally not effective for brain recovery” in people over 20.
He also cautions parents not to overinterpret online discussions: people who have problems are more likely to post, which can make it sound like “everybody has trouble with inulin.” In his clinical experience, the majority of children do fine on “lowish doses.”
Pattern #1: intolerance to even tiny doses
Dr. Nemechek describes a smaller subset of children who appear “very intolerant” to inulin, even at extremely small amounts (he gives examples like 1/32 or 1/16 of a teaspoon). In these cases, parents may report a cluster of symptoms after introducing inulin, such as:
- More physical hyperactivity
- Increased anxiety
- Marked hunger
- Difficulty sleeping
He interprets this symptom cluster as resembling an autonomic nervous system response, “as if they’re getting a drop in blood pressure,” where brain oxygen delivery may be slightly reduced—leading the brain to behave in an anxious, dysregulated way. He adds an observation central to his reasoning: bacteria in the small intestine can directly communicate with the autonomic nervous system.
Importantly, he states he does not fully understand the mechanism behind this intolerance and calls “we just don’t know” the honest answer. Clinically, however, his recommendation is straightforward in these cases: stop inulin and “move on to Rifaximin,” even in younger children, because he has seen children do well after that transition.
Pattern #2: “inulin failure” after months or years of progress
The more common scenario he describes is a child who initially does well—sometimes for 6 months, 12 months, or even longer—then suddenly reaches a standstill. Parents may notice:
- No further developmental or behavioral progression
- Sometimes mild backsliding in behavior
Dr. Nemechek characterizes this as “simple inulin failure,” meaning the inulin has stopped doing the job of controlling the relevant gut imbalance. He emphasizes that this does not mean recovery is over or that nothing else can improve; rather, it signals that the gut-bacteria strategy needs to change.
His proposed explanation: normal, age-related shifts in gut bacteria
While he says the exact reason is not fully clear, he points to a broader biological pattern: from birth through about age 20, gut bacteria in both the small intestine and colon naturally change as part of normal development. He then describes a relative stability from about 20 to 70, followed by changes again after about 70.
In his clinical interpretation, if a child starts inulin at age 3 and it stops working by age 7 (for example), that may reflect this normal developmental shift—where the bacteria involved in the overgrowth phenomenon are no longer controlled by inulin. He explicitly frames this as not a “bad sign,” but part of the process of adjusting the plan as the gut ecosystem changes.
What he changes—and what he doesn’t—when progress stalls
Dr. Nemechek advises parents not to chase small adjustments in fish oil and olive oil when progress stalls, saying the “problem’s gonna be” in balancing the gut bacteria rather than in fine-tuning the oils.
When intolerance occurs or when inulin failure happens after a plateau, he recommends stopping inulin and treating with rifaximin. After a completed 10-day course, he says he does not restart inulin. He notes he believes restarting would likely be harmless aside from possible gas if the dose is too high, but in his practice he prefers to keep the steps and the day-to-day plan minimal and does not expect inulin to work again once that shift has occurred.
Key takeaway for families
In Dr. Nemechek’s framework, a plateau after months on inulin is often a signal to reassess gut balance rather than a sign that a child is “done” improving. The key clinical forks he highlights are (1) immediate intolerance at tiny doses and (2) later “inulin failure” after a period of good progress. In both cases, his next step is to stop inulin and transition to rifaximin as the gut-directed strategy.
Educational medical disclaimer: This article is for general education and summarizes Dr. Nemechek’s comments from the referenced video. It is not medical advice and is not a substitute for individualized care. Do not start, stop, or change supplements or prescription medications (including antibiotics) without guidance from your licensed clinician.
